LH News and Press, Laboratory Corporation of America Holdings From 07/28/22

Laboratory Corporation of America press release ( NYSE: LH ): Q2 Non-GAAP EPS of $4.96 beats by $0.28 . Revenue of $3.7B (-3.6% Y/Y) misses by $60M . Free Cash Flow: Q2 of $429 million versus $390 million last year Full-Year 2022 Guidance: Adjusted EPS rais...

Company To Spin-Off Clinical Development Business Revenue: Q2 of $3.7 billion versus $3.8 billion last year Diluted EPS: Q2 of $3.87 versus $4.76 last year Adjusted EPS: Q2 of $4.96 versus $6.13 last year Free Cash Flow: Q2 of $429 million versus $390 million last ...

Clinical Development Business to be a Leading, Pure-Play Contract Research Organization with a Comprehensive Set of Clinical Trial Management, Market Access and Technology Capabilities Labcorp Remains a Leader in the Laboratory Market with Highly Complementary, Laboratory-Focu...

Laboratory Corporation of America ( NYSE: LH ), or Labcorp, is planning to spinoff its unit that focuses on clinical drug trials, the Wall Street Journal (WSJ) reported on Thursday, citing people familiar with the matter. The move by Labcorp will create a new standalon...

Laboratory Corporation of America ( NYSE: LH ) is scheduled to announce Q2 earnings results on Thursday, July 28th, before market open. The consensus EPS Estimate is $4.68 (-23.7% Y/Y) and the consensus Revenue Estimate is $3.76B (-2.1% Y/Y). Over the last 2 years, LH ...

Thinking more about ETF options for the pandemic, one might consider something like medical devices. Medical devices often have interesting economics, namely high barriers to entry once MDs become comfortable with them, high prices, and often recurring revenue elements. This is, o...

Peak inflation will likely underpin stock market performance in the second half of the year, but at the same time equities are already pricing in a 40% chance of a recession, according to UBS. Looking for better risk/reward, the equities team is getting incrementally defensive by up...

Receives Designation as a Best Place to Work for Disability Inclusion Labcorp (NYSE: LH), a leading global life sciences company, today announced that it scored 100, the highest score possible, on the 2022 Disability Equality Index® (DEI), a comprehensive benchm...

Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...

Stinging Insect Component Testing Combined with Interpretative Report Offers Enhanced Patient Management Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially life-threate...